Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,240 · see citing works

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

Chomczyński, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 47,092 · see citing works

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · see citing works

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224 · see citing works

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290 · see citing works

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997 · see citing works

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789 · see citing works

Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis

Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,684 · see citing works

In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.

Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.1.191 · Cited by 1,673 · see citing works

c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling

Grigoriadis, A. E., Wang, Z., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,260 · see citing works

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i>¹

Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201 · see citing works

Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency

Gelb, B. D., Shi, G., Chapman, H. A., & Desnick, R. J. (1996) · Science · doi:10.1126/science.273.5279.1236 · Cited by 1,022 · see citing works

Requirement for NF-κB in osteoclast and B-cell development

Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes &amp; Development · doi:10.1101/gad.11.24.3482 · Cited by 996 · see citing works

Osteopetrosis in mice lacking NF-κB1 and NF-κB2

Iotsova, V., Caamaño, J., Loy, J. K., Yang, Y., Lewin, A. C., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990 · see citing works

TGFβ Signaling: Receptors, Transducers, and Mad Proteins

Massagué, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81296-9 · Cited by 836 · see citing works

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

Tsuda, E., Goto, M., Mochizuki, S.-I., Yano, K., Kobayashi, F., Morinaga, T., & Higashio, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6603 · Cited by 787 · see citing works

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741 · see citing works

Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur.

Joyce, M. E., Roberts, A. B., Sporn, M. B., & Bolander, M. E. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.110.6.2195 · Cited by 732 · see citing works

Osteoclast-Like Cell Formation and its Regulation by Osteotropic Hormones in Mouse Bone Marrow Cultures*

Takahashi, N., Yamana, H., Yoshiki, S., Roodman, G. D., Mundy, G. R., Jones, S. J., BOYDE, A., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-122-4-1373 · Cited by 731 · see citing works

In VivoStimulation of Bone Formation by Transforming Growth Factor-β

Noda, M., & Camilliere, J. J. (1989) · Endocrinology · doi:10.1210/endo-124-6-2991 · Cited by 582 · see citing works

Advances in Bone Biology: The Osteoclast*

Roodman, G. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-308 · Cited by 553 · see citing works

The Nonamer UUAUUUAUU Is the Key AU-Rich Sequence Motif That Mediates mRNA Degradation

Zubiaga, A. M., Belasco, J. G., & Greenberg, M. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2219 · Cited by 543 · see citing works

Osteopetrosis in mice lacking haematopoietic transcription factor PU.1

Tondravi, M. M., McKercher, S. R., Anderson, K., Erdmann, J. M., Quiroz, M. E., Maki, R. A., & Teitelbaum, S. L. (1997) · Nature · doi:10.1038/386081a0 · Cited by 537 · see citing works

Transforming Growth Factor-β Gene Family Members and Bone*

Horowitz, M. C., Wozney, J. M., & McCarthy, T. L. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-27 · Cited by 496 · see citing works

The Bone Marrow-Derived Stromal Cell Lines MC3T3-G2/PA6 and ST2 Support Osteoclast-Like Cell Differentiation in Cocultures with Mouse Spleen Cells

Udagawa, N., Takahashi, N., Akatsu, T., Sasaki, T., Yamaguchi, A., KODAMA, H., Martin, T. J., & Suda, T. (1989) · Endocrinology · doi:10.1210/endo-125-4-1805 · Cited by 492 · see citing works

Regulation of Osteoclast Function

Suda, T., Nakamura, I., Jimi, E., & Takahashi, N. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.869 · Cited by 404 · see citing works

Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.

Tashjian, A. H., Voelkel, E. F., Lazzaro, M., Singer, F. R., Roberts, A. B., Derynck, R., Winkler, M. E., & Levine, L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4535 · Cited by 381 · see citing works

Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.

Chenu, C., Pfeilschifter, J., Mundy, G. R., & Roodman, G. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5683 · Cited by 295 · see citing works

B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac.

Ogawa, M., Nishikawa, S.-I., Ikuta, K., Yamamura, F., Naito, M., Takahashi, K., & Nishikawa, S.-I. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02949.x · Cited by 281 · see citing works

Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures.

Pfeilschifter, J., Seyedin, S. M., & Mundy, G. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113647 · Cited by 261 · see citing works

Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor

Yamaguchi, K., Kinosaki, M., Goto, M., Kobayashi, F., Tsuda, E., Morinaga, T., & Higashio, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5117 · Cited by 200 · see citing works

K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney.

Watanabe, K., Yamada, H., & Yamaguchi, Y. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.5.1207 · Cited by 154 · see citing works

A new preadipose cell line derived from newborn mouse calvaria can promote the proliferation of pluripotent hemopoietic stem cells in vitro

Kodama, H., Amagai, Y., Koyama, H., & Kasai, S. (1982) · Journal of Cellular Physiology · doi:10.1002/jcp.1041120114 · Cited by 136 · see citing works

Biphasic Effects of Transforming Growth Factor-β on the Production of Osteoclast-Like Cells in Mouse Bone Marrow Cultures: The Role of Prostaglandins in the Generation of These Cells

SHINAR, D. M., & Rodan, G. A. (1990) · Endocrinology · doi:10.1210/endo-126-6-3153 · Cited by 129 · see citing works

Inhibiting and stimulating effects of TGF-β1 on osteoclastic bone resorption in fetal mouse bone organ cultures

Dieudonné, S. C., Foo, P., van Zoelen, E. J. J., & Burger, E. H. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060509 · Cited by 88 · see citing works

Effects of transforming growth factor β1 on the regulation of osteoclastic development and function

Hattersley, G., & Chambers, T. J. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060210 · Cited by 74 · see citing works

The complete cDNA sequence of mouse elongation factor 1 alpha (EF 1 alpha) mRNA

Lu, X., & Werner, D. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.1.442 · Cited by 48 · see citing works

Minireview: The OPG/RANKL/RANK System

Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515 · see citing works

RANK is essential for osteoclast and lymph node development.

Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes &amp; Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478 · see citing works

Autologous platelets as a source of proteins for healing and tissue regeneration

Anitua, E., Andı́a, I., Ardanza, B., Nurden, P., & Nurden, A. T. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-07-0440 · Cited by 1,496 · see citing works

The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,167 · see citing works

Changes in Proinflammatory Cytokine Activity after Menopause

Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 911 · see citing works

Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1

Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell’Aquila, M. L., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 758 · see citing works

Transforming Growth Factor-β1 to the Bone

Janssens, K., ten Dijke, P., Janssens, S., & Van Hul, W. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0001 · Cited by 710 · see citing works

Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

Hofbauer, L. C., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., & Khosla, S. (1999) · Bone · doi:10.1016/s8756-3282(99)00162-3 · Cited by 630 · see citing works

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586 · see citing works

Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1

Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536 · see citing works

TGF‐β‐induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation

Alliston, T., Choy, L., Ducy, P., Karsenty, G., & Derynck, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2254 · Cited by 526 · see citing works

Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

Pearse, R. N., Sordillo, E. M., Yaccoby, S., Wong, B. R., Liau, D. F., Colman, N., Michaeli, J., Epstein, J., & Choi, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201394498 · Cited by 518 · see citing works

B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo

Li, Y., Toraldo, G., Li, A., Yang, X., Zhang, H., Qian, W.-P., & Weitzmann, M. N. (2007) · Blood · doi:10.1182/blood-2006-07-037994 · Cited by 520 · see citing works

Bone remodeling: an operational process ensuring survival and bone mechanical competence

Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482 · see citing works

A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and Function

Takahashi, N., Udagawa, N., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0252 · Cited by 461 · see citing works

How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis?

Preshaw, P. M., & Taylor, J. J. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01671.x · Cited by 425 · see citing works

RANK/RANKL: Regulators of Immune Responses and Bone Physiology

Leibbrandt, A., & Penninger, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.016 · Cited by 420 · see citing works

Activated T Lymphocytes Support Osteoclast Formation in Vitro

Horwood, N. J., Kartsogiannis, V., Quinn, J. M. W., Romas, E., Martin, T. J., & Gillespie, M. T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1623 · Cited by 416 · see citing works

Bone regeneration and stem cells

Arvidson, K., Abdallah, B. M., Applegate, L. A., Baldini, N., Cenni, E., Gómez‐Barrena, E., Granchi, D., Kassem, M. S., Konttinen, Y. T., Mustafa, K. B. E., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01224.x · Cited by 406 · see citing works

RANK Ligand and Osteoprotegerin

Schoppet, M., Preissner, K. T., & Hofbauer, L. C. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012303.37971.da · Cited by 403 · see citing works

Osteoprotegerin Produced by Osteoblasts Is an Important Regulator in Osteoclast Development and Function

Udagawa, N., Takahashi, N., Yasuda, H., Mizuno, A., Itoh, K., Ueno, Y., Shinki, T., Gillespie, M. T., Martin, T. J., Higashio, K., et al. (2000) · Endocrinology · doi:10.1210/endo.141.9.7634 · Cited by 403 · see citing works

Rheumatic diseases: the effects of inflammation on bone

Walsh, N. C., Crotti, T. N., Goldring, S. R., & Gravallese, E. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00338.x · Cited by 381 · see citing works

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.

Yano, K., Tsuda, E., Washida, N., Kobayashi, F., Goto, M., Harada, A., Ikeda, K., Higashio, K., & Yamada, Y. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.4.518 · Cited by 363 · see citing works

The role of the immune system in the pathophysiology of osteoporosis

Clowes, J. A., Riggs, B. L., & Khosla, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00334.x · Cited by 361 · see citing works

Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts

Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., Toyama, Y., Yabe, Y., Kumegawa, M., & Hakeda, Y. (2000) · Bone · doi:10.1016/s8756-3282(00)00358-6 · Cited by 347 · see citing works

MLO-Y4 Osteocyte-Like Cells Support Osteoclast Formation and Activation

Zhao, S., Kato, Y., Zhang, Y., Harris, S., Ahuja, S. S., & Bonewald, L. F. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.11.2068 · Cited by 322 · see citing works

Cytokine responses against periodontal infection: protective and destructive roles

Liu, Y.-C. G., Lerner, U. H., & Teng, Y.-T. A. (2009) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00321.x · Cited by 304 · see citing works

A novel molecular mechanism modulating osteoclast differentiation and function

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Goto, M., Mochizuki, S.-I., Tsuda, E., Morinaga, T., Udagawa, N., et al. (1999) · Bone · doi:10.1016/s8756-3282(99)00121-0 · Cited by 262 · see citing works

The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis

Weitzmann, M. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 270 · see citing works

The Smad Dependent TGF-β and BMP Signaling Pathway in Bone Remodeling and Therapies

Zou, M., Chen, Z.-H., Teng, Y., Liu, S.-Y., Yuan, J., Zhang, K., Sun, Z., Wu, J., Yuan, Z., Feng, Y., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.593310 · Cited by 243 · see citing works

Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

Quinn, J. M. W., Itoh, K., Udagawa, N., Häusler, K., Yasuda, H., Shima, N., Mizuno, A., Higashio, K., Takahashi, N., Suda, T., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1787 · Cited by 278 · see citing works

Osteoprotegerin and RANK ligand expression in prostate cancer.

Brown, J. M., Corey, E., Lee, Z. D., True, L. D., Yun, T. J., Tondravi, M., & Vessella, R. L. (2001) · Urology · doi:10.1016/s0090-4295(00)01122-5 · Cited by 234 · see citing works

TRANCE is a TNF family member that regulates dendritic cell and osteoclast function

Wong, B. R., Josien, R., & Choi, Y. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.6.715 · Cited by 230 · see citing works

Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity

Lossdörfer, S., Schwartz, Z., Wang, L., Lohmann, C. H., Turner, J. D., Wieland, M., Cochran, D. L., & Boyan, B. D. (2004) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30025 · Cited by 227 · see citing works

Pathogenesis of Age-Related Bone Loss in Humans

Khosla, S. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls163 · Cited by 222 · see citing works

Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.

Locklin, R. M., Khosla, S., Turner, R. T., & Riggs, B. L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10490 · Cited by 219 · see citing works

Circulating Osteoprotegerin and Receptor Activator for Nuclear Factor κB Ligand: Clinical Utility in Metabolic Bone Disease Assessment

Rogers, A., & Eastell, R. (2005) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2005-0794 · Cited by 215 · see citing works

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

HOROWITZ, M., Xi, Y., WILSON, K., & Kacena, M. A. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00030-7 · Cited by 215 · see citing works

Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice

Chagraoui, H., Komura, E., Tulliez, M., Giraudier, S., Vainchenker, W., & Wendling, F. (2002) · Blood · doi:10.1182/blood-2002-04-1133 · Cited by 238 · see citing works

Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass

Filvaroff, E. H., Erlebacher, A., Ye, J., Gitelman, S. E., Lotz, J. C., Heilman, M., & Derynck, R. (1999) · Development · doi:10.1242/dev.126.19.4267 · Cited by 212 · see citing works

A role for TGFβ1 in osteoclast differentiation and survival

Fuller, K., Lean, J. M., Bayley, K. E., Wani, M. R., & Chambers, T. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.13.2445 · Cited by 199 · see citing works

Linked Deficiencies in Extracellular PPi and Osteopontin Mediate Pathologic Calcification Associated With Defective PC-1 and ANK Expression

Johnson, K., Goding, J. W., Etten, D. V., Sali, A., Hu, S., FARLEY, D. L., Krug, H. E., Hessle, L., Millán, J. L., & Terkeltaub, R. A. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.994 · Cited by 198 · see citing works

Authentic Matrix Vesicles Contain Active Metalloproteases (MMP)

D’Angelo, M., Billings, P. C., Pacifici, M., Leboy, P. S., & Kirsch, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009725200 · Cited by 195 · see citing works

17β-Estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-α.

Saika, M., Inoue, D., Kido, S., & Matsumoto, T. (2001) · Endocrinology · doi:10.1210/endo.142.6.8220 · Cited by 194 · see citing works

Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures

Langdahl, B. L., Carstens, M., Stenkjær, L. L., & Eriksen, E. F. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1245 · Cited by 189 · see citing works

Osteocytes inhibit osteoclastic bone resorption through transforming growth factor‐β: Enhancement by estrogen*

Heino, T. J., Hentunen, T. A., & Väänänen, H. K. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10109 · Cited by 191 · see citing works

Roles of stromal cell RANKL, OPG, and M‐CSF expression in biphasic TGF‐β regulation of osteoclast differentiation

Karst, M., Gorny, G., Galvin, R. J. S., & Oursler, M. J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20036 · Cited by 184 · see citing works

Genetic Disorders of the Skeleton: A Developmental Approach

Kornak, U., & Mundlos, S. (2003) · The American Journal of Human Genetics · doi:10.1086/377110 · Cited by 180 · see citing works

Prostaglandin E2 Induces Expression of Receptor Activator of Nuclear Factor–κB Ligand/Osteoprotegrin Ligand on Pre-B Cells: Implications for Accelerated Osteoclastogenesis in Estrogen Deficiency

Kanematsu, M., Sato, T., Takai, H., Watanabe, K., Ikeda, K., & Yamada, Y. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.7.1321 · Cited by 174 · see citing works

The Role of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases

Hofbauer, L. C., & Heufelder, A. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6702 · Cited by 175 · see citing works

Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor

Zannettino, A. C. W., Holding, C. A., Diamond, P., Atkins, G. J., Kostakis, P., Farrugia, A., Gamble, J. R., To, L. B., Findlay, D. M., & Haynes, D. R. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20354 · Cited by 166 · see citing works

Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces

Rausch‐Fan, X., Qu, Z., Wieland, M., Matejka, M., & Schedle, A. (2007) · Dental Materials · doi:10.1016/j.dental.2007.03.001 · Cited by 151 · see citing works

Molecular mechanisms underlying osteoclast formation and activation

Troen, B. R. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00069-x · Cited by 147 · see citing works

Root resorption and the OPG/RANKL/RANK system: a mini review

Tyrovola, J. B., Spyropoulos, M. N., Makou, M., & Perrea, D. N. (2008) · Journal of Oral Science · doi:10.2334/josnusd.50.367 · Cited by 142 · see citing works

TGF-β in cancer and bone: Implications for treatment of bone metastases

Juárez, P., & Guise, T. A. (2010) · Bone · doi:10.1016/j.bone.2010.08.004 · Cited by 143 · see citing works

Tumor necrosis factor‐α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism †

Zou, W., Hakim, I., Tschoep, K., Endres, S., & Bar-Shavit, Z. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1202 · Cited by 152 · see citing works

Transforming Growth Factor-β Controls Human Osteoclastogenesis through the p38 MAPK and Regulation of RANK Expression

Karsdal, M. A., Hjorth, P., Henriksen, K., Kirkegaard, T., Nielsen, K. L., Lou, H., Delaissé, J., & Foged, N. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303905200 · Cited by 137 · see citing works

Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β)

Thirunavukkarasu, K., Miles, R. R., Halladay, D., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104319200 · Cited by 138 · see citing works

Role of periodontal ligament fibroblasts in osteoclastogenesis: a review.

Sokos, D., Everts, V., & de Vries, T. D. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12197 · Cited by 130 · see citing works

TGF-β Enhances Osteoclast Differentiation in Hematopoietic Cell Cultures Stimulated with RANKL and M-CSF

Galvin, R. J. S., Gatlin, C. L., Horn, J. W., & Fuson, T. R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1632 · Cited by 132 · see citing works

TGF-beta1 on osteoimmunology and the bone component cells

Kasagi, S., & Chen, W. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-4 · Cited by 131 · see citing works

Biochemical Characterization and Expression Analysis of Neural Thrombospondin-1-like Proteins NELL1 and NELL2

Kuroda, S., Oyasu, M., Kawakami, M., Kanayama, N., Tanizawa, K., Saito, N., Abe, T., Matsuhashi, S., & Ting, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1638 · Cited by 131 · see citing works

Pathophysiological roles of osteoprotegerin (OPG)

Reid, P. E., & Holen, I. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.06.004 · Cited by 128 · see citing works

Regulatory roles and molecular signaling of TNF family members in osteoclasts

Feng, X. (2005) · Gene · doi:10.1016/j.gene.2005.01.014 · Cited by 131 · see citing works

The Ratio of Messenger RNA Levels of Receptor Activator of Nuclear Factor κB Ligand to Osteoprotegerin Correlates with Bone Remodeling Indices in Normal Human Cancellous Bone but Not in Osteoarthritis

Fazzalari, N. L., Kuliwaba, J. S., Atkins, G. J., Forwood, M. R., & Findlay, D. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1015 · Cited by 129 · see citing works

Platelet-Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory Factor

Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T., & Wakabayashi, K. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.257 · Cited by 130 · see citing works

Transforming Growth Factor-β1 Mutations in Camurati-Engelmann Disease Lead to Increased Signaling by Altering either Activation or Secretion of the Mutant Protein

Janssens, K., ten Dijke, P., Ralston, S. H., Bergmann, C., & Hul, W. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208857200 · Cited by 122 · see citing works

Force-Induced Osteoclast Apoptosis In Vivo Is Accompanied by Elevation in Transforming Growth Factor β and Osteoprotegerin Expression

Kobayashi, Y., Hashimoto, F., Miyamoto, H., Kanaoka, K., Miyazaki-Kawashita, Y., Nakashima, T., Shibata, M., Kobayashi, K., Kato, Y., & Sakai, H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1924 · Cited by 121 · see citing works

Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism

Hofbauer, L. C. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410195 · Cited by 120 · see citing works

Endogenous Production of TGF-β Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-κB Ligand and Macrophage-Colony- Stimulating Factor

Kaneda, T., Nojima, T., Nakagawa, M., Ogasawara, A., Kaneko, H., Sato, T., Mano, H., Kumegawa, M., & Hakeda, Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4254 · Cited by 119 · see citing works

Transforming growth factor-β induces osteoclast formation in the absence of RANKL

Itonaga, I., Sabokbar, A., Sun, S. G., Kudo, O., Danks, L., Ferguson, D. J. P., Fujikawa, Y., & Athanasou, N. A. (2003) · Bone · doi:10.1016/j.bone.2003.08.008 · Cited by 119 · see citing works

Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin‐deficient mice

Oshiro, T., Shiotani, A., Shibasaki, Y., & Sasaki, T. (2002) · The Anatomical Record · doi:10.1002/ar.10061 · Cited by 115 · see citing works

Nitric Oxide Regulates Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin Expression in Bone Marrow Stromal Cells

Fan, X., Roy, E., Zhu, L., Murphy, T. C., Ackert‐Bicknell, C. L., Hart, C. M., Rosen, C. J., Nanes, M. S., & Rubin, J. E. (2003) · Endocrinology · doi:10.1210/en.2003-0726 · Cited by 117 · see citing works

Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement

Mandelin, J. M., Li, T.-F., Liljeström, M., Kroon, M. E., Hanemaaijer, R., Santavirta, S. S., & Konttinen, Y. T. (2003) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.85b8.13311 · Cited by 117 · see citing works

Expression of receptor activator of NF‐kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells

Hasegawa, T., Yoshimura, Y., Kikuiri, T., Yawaka, Y., Takeyama, S., Matsumoto, A., Oguchi, H., & Shirakawa, T. (2002) · Journal of Periodontal Research · doi:10.1034/j.1600-0765.2002.01603.x · Cited by 116 · see citing works

TGF-β Family Signaling in Connective Tissue and Skeletal DiseasesPreprint

MacFarlane, E. G., Haupt, J., Dietz, H. C., & Shore, E. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022269 · Cited by 119 · see citing works

Functional α1‐ and β2‐adrenergic receptors in human osteoblasts

Huang, H., Brennan‐Speranza, T. C., Muir, M. M., & Mason, R. S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21761 · Cited by 115 · see citing works

Osteoclast formation and resorption

Lerner, U. H. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00052-4 · Cited by 114 · see citing works

Bone Morphogenetic Protein-2 Enhances Osteoclast Formation Mediated by Interleukin-1α through Upregulation of Osteoclast Differentiation Factor and Cyclooxygenase-2

Koide, M., Murase, Y., Yamato, K., Noguchi, T., Okahashi, N., & Nishihara, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0715 · Cited by 109 · see citing works

Regulation of osteoclastogenesis and RANK expression by TGF‐β1

Yan, T., Riggs, B. L., Boyle, W. J., & Khosla, S. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1200 · Cited by 109 · see citing works

RANK-Fc: A therapeutic antagonist for RANK-L in myeloma

Sordillo, E. M., & Pearse, R. N. (2003) · Cancer · doi:10.1002/cncr.11134 · Cited by 109 · see citing works

The Role of Mast Cells in Bone Metabolism and Bone Disorders

Ragipoglu, D., Dudeck, A., Haffner‐Luntzer, M., Voß, M., Kroner, J., Ignatius, A. A., & Fischer, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00163 · Cited by 109 · see citing works

Smad4 is required for maintaining normal murine postnatal bone homeostasis

Tan, X., Weng, T., Zhang, J., Jian, W., Li, W., Wan, H., Lan, Y., Cheng, X., Hou, N., Liu, H., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03466 · Cited by 106 · see citing works

Transcriptional Mechanisms of Bone Morphogenetic Protein-induced Osteoprotegrin Gene Expression

Wan, M., Shi, X., Feng, X., & Cao, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006918200 · Cited by 104 · see citing works

Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels

Kondo, T., Kitazawa, R., Yamaguchi, A., & Kitazawa, S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21414 · Cited by 103 · see citing works

Expression of Osteoprotegerin (Osteoclastogenesis Inhibitory Factor) in Cultures of Human Dental Mesenchymal Cells and Epithelial Cells

Sakata, M., Shiba, H., Komatsuzawa, H., Fujita, T., Ohta, K., Sugai, M., Suginaka, H., & Kurihara, H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1486 · Cited by 103 · see citing works

HIV: Inflammation and Bone

Ofotokun, I., McIntosh, E. B., & Weitzmann, M. N. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0099-z · Cited by 99 · see citing works

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO

Chagraoui, H., Tulliez, M., Smayra, T., Komura, E., Giraudier, S., Yun, T. J., Lassau, N., Vainchenker, W., & Wendling, F. (2003) · Blood · doi:10.1182/blood-2002-09-2839 · Cited by 97 · see citing works

RANKL-independent modulation of osteoclastogenesis

Feng, W., Guo, J., & Li, M. (2019) · Journal of Oral Biosciences · doi:10.1016/j.job.2019.01.001 · Cited by 96 · see citing works

Cyclical Tensile Force on Periodontal Ligament Cells Inhibits Osteoclastogenesis through OPG Induction

Kanzaki, H., Chiba, M., Satô, A., Miyagawa, A., Arai, K., NUKATSUKA, S., & Mitani, H. (2006) · Journal of Dental Research · doi:10.1177/154405910608500512 · Cited by 96 · see citing works

Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-κB ligand

Buckley, K. M., Hipskind, R. A., Gartland, A., Bowler, W. B., & Gallagher, J. A. (2002) · Bone · doi:10.1016/s8756-3282(02)00877-3 · Cited by 97 · see citing works

Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders

Workgroup, O. B. O. T. E. R. O. (., Carrillo-López, N., Martínez-Arias, L., Fernández-Villabrille, S., Ruiz-Torres, M. P., Dusso, A., Cannata-Andía, J. B., Naves-Díaz, M., & Panizo, S. (2021) · Calcified Tissue International · doi:10.1007/s00223-020-00803-2 · Cited by 91 · see citing works

Current insights into the role of transforming growth factor-β in bone resorption

Fox, S. W., & Lovibond, A. C. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.09.008 · Cited by 90 · see citing works

Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease

Ernst, C. W. O., Lee, J. E., Nakanishi, T., Karimbux, N. Y., Rezende, T. M. B., Stashenko, P., Seki, M., Taubman, M. A., & Kawai, T. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03318.x · Cited by 90 · see citing works

The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance

Eagar, T. N., Karandikar, N. J., Bluestone, J. A., & Miller, S. D. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4 · Cited by 108 · see citing works

Transforming Growth Factor-β Induces Expression of Receptor Activator of NF-κB Ligand in Vascular Endothelial Cells Derived from Bone

Ishida, A., Fujita, N., Kitazawa, R., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111093200 · Cited by 86 · see citing works

Interleukin-18 Up-Regulates Osteoprotegerin Expression in Stromal/Osteoblastic Cells

Makiishi-Shimobayashi, C., Tsujimura, T., Iwasaki, T., Yamada, N., Sugihara, A., Okamura, H., Hayashi, S., & Terada, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4380 · Cited by 86 · see citing works

Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors

Darnay, B. G., & Aggarwal, B. B. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i2 · Cited by 84 · see citing works

Macrophage lineage phenotypes and osteoclastogenesis—Complexity in the control by GM-CSF and TGF-β

Lari, R., Fleetwood, A. J., Kitchener, P. D., Cook, A. D., Pavasovic, D., Hertzog, P. J., & Hamilton, J. A. (2006) · Bone · doi:10.1016/j.bone.2006.09.003 · Cited by 82 · see citing works

Estrogen Modulates Cytokine Expression in Human Periodontal Ligament Cells

Shu, L., Guan, S., Fu, S., Guo, T., Cao, M., & Ding, Y. (2008) · Journal of Dental Research · doi:10.1177/154405910808700214 · Cited by 82 · see citing works

Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like Cells

Murakami, T., Yamamoto, M., Yamamoto, M., Ono, K., Nishikawa, M., Nagata, N., Motoyoshi, K., & Akatsu, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9723 · Cited by 195 · see citing works

16. Lack of antagonist activity of melanocyte-stimulating hormone (MSH) on the actions of IL-1 on human bone-derived osteoblast-like cells

Evans, D., Thavarajah, M., & Kanis, J. A. (1991) · Bone · doi:10.1016/8756-3282(91)90112-v

Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β)

Thirunavukkarasu, K., Miles, R. R., Halladay, D., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104319200 · Cited by 138 · see citing works

Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

Hofbauer, L. C., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., & Khosla, S. (1999) · Bone · doi:10.1016/s8756-3282(99)00162-3 · Cited by 630 · see citing works

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i>¹

Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201 · see citing works